TP53 and neoplasm: They found that TP53-wt/MSI-H tumor cells were more sensitive to WRN loss than TP53-mut/MSI-H cells; they also found an increased expression of the CDK inhibitor p21 subsequent to a WRN depletion, which is a response to TP53 activation.